• Gary D. Blackford

    • Chairman of the Board

    Gary D. Blackford was elected to our Board in October 2014.  He was appointed as Chairman of our Board in April 2020. From 2002 until February 2015, Mr. Blackford was the Chairman of the Board and Chief Executive Officer of Universal Hospital Services, Inc. (“UHS”), a leading nationwide provider of medical technology outsourcing and services to the health care industry. Mr. Blackford was the Chief Executive Officer of Curative Health Services, Inc., a specialty pharmacy and health services company, from 2001 to 2002. He was also the Chief Executive Officer of ShopforSchool, Inc., an online retailer, from 1999 to 2001.  Mr. Blackford has also been a director of ReShape Lifesciences, Inc. (RSLS) since 2016 (and Lead Director since 2019), Children’s Hospitals and Clinics of Minnesota since 2017 (and Chairman since 2020), and Advanced Tissue, Inc. since 2020.  He was a director of Wright Medical Group, N.V. from 2008 to 2020 and PipelineRX, Inc. from 2016 to 2020.  Mr. Blackford was selected to serve as a member of our Board of Directors due to his executive leadership experience as a chief executive officer, financial literacy and experience in finance and accounting, international experience, and governance and public company board experience.

  • John P. Byrnes

    John P. Byrnes was elected to our Board in October 2014. He is the Chair of our Compliance Committee.  Mr. Byrnes served as the Chairman of the Board of Lincare Holdings, Inc. (“Lincare”), a provider of home respiratory care, infusion therapy and medical equipment, from March 2000 through March 2015, and as a director of Lincare from May 1997 to August 2015. Mr. Byrnes was the Chief Executive Officer of Lincare from 1997 until March 2015 and served as Lincare’s President from June 1996 until April 2003. Prior to becoming Lincare’s President, Mr. Byrnes served in a number of capacities at Lincare over a ten-year period, including serving as Chief Operating Officer throughout 1996. Mr. Byrnes was a director of Kinetic Concepts, Inc., a global medical technology company devoted to the discovery, development, manufacturing and marketing of innovative, high-technology therapies and products, from January 2003 until February 2011 and of U.S. RenalCare, Inc., a dialysis provider, from August 2005 until 2012. Mr. Byrnes also was a director of Tenet Healthcare Corporation from November 2016 until May 2018.  Mr. Byrnes was selected to serve as a member of our Board of Directors due to his leadership experience as a chief executive officer, knowledge of, and experience in, the healthcare industry, international experience and governance and public company board experience.

  • Patrick J. O’Leary

    Patrick J. O’Leary was elected to our Board in October 2014. He is the Chairman of our Audit Committee.  Mr. O’Leary served as Executive Vice President and Chief Financial Officer of SPX Corporation, a global industrial and technological services and products company, from December 2004 until August 2012, when he retired. Prior to that time, he served as Chief Financial Officer and Treasurer of SPX Corporation from October 1996 to December 2004.  Mr. O’Leary has been a director and Chairman of SPX Corporation (SPXC) since 2015.  He was a Director of PulteGroup, Inc. (PHM), since 2005 to 2018. Mr. O’Leary has been selected to serve as a member of our Board of Directors due to his executive leadership experience as a chief financial officer, financial literacy and experience in finance and accounting, international experience, and governance and public company board experience.

  • Maria Sainz

    Maria Sainz was elected to our Board effective February 1, 2015. Ms. Sainz served as the CEO of Aegea Medical, a medical device company in the women’s health space focused on the development of technology for endometrial ablation, from May 2018 through February 2021.  Prior to that, she served as the President and CEO of Cardiokinetix, a medical device company, from May 2012 until July 2017. She was the President and CEO of Concentric Medical, Inc., a medical technology company, from April 2008 until May 2012. In 2011, Concentric Medical was acquired by Stryker Corporation, where she was named General Manager of the business unit of Stryker Neurovascular. Ms. Sainz led integration activities following the acquisition of Guidant Corporation by Boston Scientific from 2006 to 2008. She served as President of the Cardiac Surgery division of Guidant from February 2003 through July 2006. Ms. Sainz served as Vice President, Global Marketing for the Vascular Intervention division of Guidant from January 2001 through February 2003. Ms. Sainz served as Vice President of the Intermedics Cardiac Rhythm Management business of Guidant in Europe, from 1998 to 2001. Ms. Sainz also serves as a director of ShockWave Medical (SWAV) and Orthofix International, N.V. (OFIX), and also Levita Magnetics and Artio Medical, Inc., both early stage, private companies. Ms. Sainz was selected to serve as a member of our Board of Directors due to her leadership experience as a chief executive officer, knowledge of, and experience in, the healthcare industry, international experience, and public company board experience.

  • Dr. Julie Shimer

    Dr. Julie Shimer elected to our Board in October 2014. She is the Chairwoman of the Governance Committee. Dr. Shimer is currently a private investor and has 30 years of product development experience, including many years with major communications companies. From March 2007 to April 2012 she served as Chief Executive Officer of Welch Allyn, Inc., a manufacturer of frontline medical products and solutions, having served on the board of directors beginning in July 2002. Previously, Dr. Shimer was President, Chief Executive Officer, and a member of the board of directors of Vocera Communications, Inc., a provider of wireless communications systems. She also has served as general manager at 3Com Corporation and Motorola and has been a product development leader at Motorola and AT&T Bell Laboratories. She has served as the Chair of Empire State Development Corp., the State of New York’s economic development organization, and as an advisor to two private companies, Kitchology, a mobile platform empowering families dealing with special diets through the power of technology and community, and CPLANE Networks, a leader in end-to-end data center and wide area network service orchestration that enables software-defined networking and network function virtualization services to be launched and managed in a single environment. Dr. Shimer also serves as a director of Apollo Endosurgery, Inc. (APEN), a medical device company focused on less invasive therapies for the treatment of obesity, and Masimo Corporation (MASI), a medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies. She was also a director of Windstream Holdings, Inc., a leading telecommunications and cloud services provider, Earthlink, Inc., an internet service provider, and Netgear, a computer networking company.  She also serves as a director of two nonprofit organizations.  Dr. Shimer was selected to serve as a member of our Board of Directors due to her leadership experience as a chief executive officer, knowledge of, and experience in, the healthcare industry, international experience and governance and public company board experience.

  • Joseph F. Woody

    Joseph F. Woody is our chief executive officer and a member of our board of directors. He brings 20 years of healthcare leadership experience, proven success driving revenue growth and expertise in spearheading portfolio transformations to our business.  

    Prior to joining Halyard, Joe served as chief executive officer and president of Acelity, where, since 2011, he was responsible for overseeing the development and commercialization of their $2 billion innovative wound care and regenerative solutions business. From 2009 to 2011, Joe served as global president, vascular therapies, for Covidien, creating their new vascular division and leading the company’s $2.6 billion acquisition and integration of ev3.

    Prior to his time at Covidien, Joe served as Smith & Nephew’s global president, advanced wound management, and Alliance Imaging’s vice president, Pacific operations. Joe previously served as board director for Acelity, the Advanced Medical Technology Association (AdvaMed) and Systagenix Wound Management. He also served as Chair of AdvaMed’s Wound Healing and Tissue Regeneration Sector.